Ken Drazan

Ken Drazan is a prominent figure in the health policy and economics sector, currently serving as an Advisory Board Member at the USC Schaeffer Center for Health Policy & Economics. He holds the position of Chairman, CEO, and Co-Founder of ArsenalBio, a biotechnology company focused on innovative cancer therapies, since January 2019.12

Background and Education

Drazan has a robust educational background, having earned a Bachelor of Arts in Economics from Yale University and a Doctor of Medicine (MD) degree from the State University of New York (SUNY) Downstate Medical Center School of Public Health, where he graduated cum laude.1

Professional Experience

His extensive career includes various leadership roles:

• President of GRAIL, Inc. from July 2017 to July 2018, where he was involved in advancing early cancer detection technologies.1
• Chief Business Officer at GRAIL, Inc. prior to his presidency.1
• He has also served as an Assistant Professor of Surgery at Stanford University School of Medicine and has held surgical positions at UCLA Health.1

In addition to his role at the USC Schaeffer Center, Drazan is actively involved in several boards and councils, including:

• Member of the Board of Directors for the University of California's Innovation Council since February 2016.1
• Co-Host of the Laguna CEO Forum since November 2023.1

Contributions and Impact

Drazan's contributions to health policy and economics are significant, particularly through his leadership at ArsenalBio and involvement with the USC Schaeffer Center, where he helps shape policies that influence healthcare delivery and innovation. His experience spans both clinical practice and executive leadership in biotechnology, making him a key player in advancing health solutions.